Cargando…

Clinical outcomes and prognostic factors of stereotactic body radiation therapy for intrahepatic cholangiocarcinoma

Stereotactic body radiation therapy (SBRT) has been an emerging non-invasive treatment modality for patients with intrahepatic cholangiocarcinoma (ICC) when surgical treatment cannot be applied. The CyberKnife(®) is a SBRT system that allows for real-time tracking of the tumor. The purpose of this s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shen, Ze-Tian, Zhou, Han, Li, Ao-Mei, Li, Bing, Shen, Jun-Shu, Zhu, Xi-Xu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5706817/ https://www.ncbi.nlm.nih.gov/pubmed/29212171 http://dx.doi.org/10.18632/oncotarget.19972

Ejemplares similares

Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
por: Venkat, Puja S., et al.
Publicado: (2017)

Stereotactic Body Radiotherapy (SBRT) for Intrahepatic and Hilar Cholangiocarcinoma
por: Mahadevan, Anand, et al.
Publicado: (2015)

Stereotactic radiotherapy for intrahepatic cholangiocarcinoma
por: Borakati, Aditya, et al.
Publicado: (2022)

Stereotactic body radiotherapy (SBRT) for locally advanced intrahepatic and extrahepatic cholangiocarcinoma
por: Gkika, Eleni, et al.
Publicado: (2017)

Stereotactic body radiotherapy (SBRT) for locally advanced extrahepatic and intrahepatic cholangiocarcinoma
por: Sandler, Kiri A., et al.
Publicado: (2016)

Stereotactic radiotherapy in intrahepatic cholangiocarcinoma: A systematic review
por: Bisello, Silvia, et al.
Publicado: (2021)

The Role of Conventional and Stereotactic Microwave Ablation for Intrahepatic Cholangiocarcinoma
por: Kim-Fuchs, Corina, et al.
Publicado: (2021)

Stereotactic body radiation therapy is associated with improved overall survival compared to chemoradiation or radioembolization in the treatment of unresectable intrahepatic cholangiocarcinoma
por: Sebastian, Nikhil T., et al.
Publicado: (2019)

Treatment outcomes and prognostic factors of intrahepatic cholangiocarcinoma
por: DHANASEKARAN, RENUMATHY, et al.
Publicado: (2013)

Clinical outcomes of CyberKnife stereotactic body radiotherapy for peripheral stage I non-small cell lung cancer
por: Shen, Ze-Tian, et al.
Publicado: (2015)

The prognostic impact of preoperative body composition in perihilar and intrahepatic cholangiocarcinoma
por: Lurje, Isabella, et al.
Publicado: (2022)

Analysis of the efficacy, safety and survival factors of stereotactic body radiation therapy in patients with recurrence of pancreatic cancer
por: Li, Jing, et al.
Publicado: (2020)

The diagnostic and prognostic value of UBE2T in intrahepatic cholangiocarcinoma
por: Yu, Hua, et al.
Publicado: (2020)

Outcomes of stereotactic body radiotherapy for unresectable primary or recurrent cholangiocarcinoma
por: Jung, Da Hoon, et al.
Publicado: (2014)

The role of microRNAs in intrahepatic cholangiocarcinoma
por: Li, Zheng, et al.
Publicado: (2016)

Impact of cirrhosis on long‐term survival outcomes of patients with intrahepatic cholangiocarcinoma
por: Wang, Jian, et al.
Publicado: (2022)

Peritumoral ductular reaction can be a prognostic factor for intrahepatic cholangiocarcinoma
por: Shen, Zhenyang, et al.
Publicado: (2020)

Prognostic Value and Predication Model of Microvascular Invasion in Patients with Intrahepatic Cholangiocarcinoma
por: Tang, Zheng, et al.
Publicado: (2019)

Development and Validation of a Nomogram for Differentiating Combined Hepatocellular Cholangiocarcinoma From Intrahepatic Cholangiocarcinoma
por: Wang, Tao, et al.
Publicado: (2020)

A Bayesian network meta-analysis of whole brain radiotherapy and stereotactic radiotherapy for brain metastasis
por: Yuan, Xi, et al.
Publicado: (2017)

Prognostic analysis of radical resection for intrahepatic cholangiocarcinoma: a retrospective cohort study
por: Ni, Qingqiang, et al.
Publicado: (2017)

Prognostic value of inflammation-based indexes for intrahepatic cholangiocarcinoma following curative resection
por: Wu, Yunhua, et al.
Publicado: (2019)

Overexpression of interleukin‐35 in intrahepatic cholangiocarcinoma is a prognostic indicator after curative resection
por: Zhang, Mei‐xia, et al.
Publicado: (2018)

The Clinical Outcomes, Prognostic Factors and Nomogram Models for Primary Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy
por: Luo, Li-Mei, et al.
Publicado: (2022)

Long-term outcome and prognostic nomogram for intrahepatic cholangiocarcinoma after thermal ablation: a retrospective study
por: Wang, Yang, et al.
Publicado: (2020)

Stereotactic Body Radiation Therapy for Cholangiocarcinoma: Optimizing Locoregional Control With Elective Nodal Irradiation
por: Kozak, Margaret M., et al.
Publicado: (2019)

Prognostic Significance of Capn4 Overexpression in Intrahepatic Cholangiocarcinoma
por: Zhang, Chi, et al.
Publicado: (2013)

Staging and Prognostic Models for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
por: Burkhart, Richard A., et al.
Publicado: (2017)

Prognostic impact of hepatitis B or C on intrahepatic cholangiocarcinoma
por: Seo, Jung Woong, et al.
Publicado: (2020)

Cirrhosis in intrahepatic cholangiocarcinoma: prognostic importance and impact on survival
por: Thakral, Nimish, et al.
Publicado: (2023)

Clinical Outcomes Using Magnetic Resonance–Guided Stereotactic Body Radiation Therapy in Patients With Locally Advanced Cholangiocarcinoma
por: Luterstein, Elaine, et al.
Publicado: (2019)

Clinicopathological and Prognostic Significance of Immunoscore and PD-L1 in Intrahepatic Cholangiocarcinoma
por: Wu, Hong, et al.
Publicado: (2021)

Characterization of intrahepatic cholangiocarcinoma after curative resection: outcome, prognostic factor, and recurrence
por: Chan, Kun-Ming, et al.
Publicado: (2018)

Systemic Immune-Inflammation Index Is a Prognostic Predictor in Patients with Intrahepatic Cholangiocarcinoma Undergoing Liver Transplantation
por: Ren, Ao, et al.
Publicado: (2021)

NRP1 is a Prognostic Factor and Promotes the Growth and Migration of Cells in Intrahepatic Cholangiocarcinoma
por: Wu, Yong-Na, et al.
Publicado: (2020)

Prognostic Value of Inflammatory and Tumour Markers in Small-Duct Subtype Intrahepatic Cholangiocarcinoma after Curative-Intent Resection
por: Ma, Bingqi, et al.
Publicado: (2021)

The influence of the extent of lymph node metastasis on the prognosis for patients with intrahepatic cholangiocarcinoma
por: Wang, Jianping, et al.
Publicado: (2023)

Intrahepatic Sarcomatoid Cholangiocarcinoma
por: Malhotra, Shalini, et al.
Publicado: (2010)

Asbestos and Intrahepatic Cholangiocarcinoma
por: Brandi, Giovanni, et al.
Publicado: (2020)

Management of Intrahepatic Cholangiocarcinoma
por: Kodali, Sudha, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_d0tq6hrml3rt86slpdomiraidk